Free Trial

PureTech Health (NASDAQ:PRTC) Trading Up 2.5% - Time to Buy?

PureTech Health logo with Medical background
Remove Ads

Shares of PureTech Health plc (NASDAQ:PRTC - Get Free Report) traded up 2.5% during mid-day trading on Monday . The stock traded as high as $18.53 and last traded at $18.25. 3,307 shares changed hands during mid-day trading, an increase of 30% from the average session volume of 2,553 shares. The stock had previously closed at $17.80.

PureTech Health Price Performance

The firm's 50 day simple moving average is $18.46 and its 200-day simple moving average is $20.15.

Institutional Trading of PureTech Health

A hedge fund recently bought a new stake in PureTech Health stock. Millennium Management LLC purchased a new position in shares of PureTech Health plc (NASDAQ:PRTC - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 45,264 shares of the company's stock, valued at approximately $823,000. Millennium Management LLC owned 0.19% of PureTech Health at the end of the most recent quarter. Institutional investors and hedge funds own 0.04% of the company's stock.

About PureTech Health

(Get Free Report)

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.

Featured Articles

Should You Invest $1,000 in PureTech Health Right Now?

Before you consider PureTech Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.

While PureTech Health currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads